Metabolic regulation of cell growth and proliferation (original) (raw)

• Galdieri, L., Mehrotra, S., Yu, S. & Vancura, A. Transcriptional regulation in yeast during diauxic shift and stationary phase. OMICS 14, 629–638 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Marijuan, P. C., Navarro, J. & del Moral, R. On prokaryotic intelligence: strategies for sensing the environment. Biosystems 99, 94–103 (2010).
  Article CAS PubMed Google Scholar
• Schaller, G. E., Shiu, S. H. & Armitage, J. P. Two-component systems and their co-option for eukaryotic signal transduction. Curr. Biol. 21, R320–R330 (2011).
  Article CAS PubMed Google Scholar
• DeBerardinis, R. J. et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl Acad. Sci. USA 104, 19345–19350 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Rheinwald, J. G. & Green, H. Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes. Nature 265, 421–424 (1977).
  Article CAS PubMed Google Scholar
• Martin, P. Wound healing—aiming for perfect skin regeneration. Science 276, 75–81 (1997).
  Article CAS PubMed Google Scholar
• Nissen, N. N. et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol. 152, 1445–1452 (1998).
  CAS PubMed PubMed Central Google Scholar
• Saltiel, A. R. & Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799–806 (2001).
  Article CAS PubMed Google Scholar
• Frauwirth, K. A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769–777 (2002).
  Article CAS PubMed Google Scholar
• Esensten, J. H., Helou, Y. A., Chopra, G., Weiss, A. & Bluestone, J. A. CD28 costimulation: from mechanism to therapy. Immunity 44, 973–988 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Barthel, A. et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J. Biol. Chem. 274, 20281–20286 (1999).
  Article CAS PubMed Google Scholar
• Rathmell, J. C. et al. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol. Cell. Biol. 23, 7315–7328 (2003). This work demonstrates that growth factor signalling is necessary for mammalian cells to maintain glucose uptake in support of bioenergetics and cell survival.
  Article CAS PubMed PubMed Central Google Scholar
• Wieman, H. L., Wofford, J. A. & Rathmell, J. C. Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol. Biol. Cell 18, 1437–1446 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Rathmell, J. C., Vander Heiden, M. G., Harris, M. H., Frauwirth, K. A. & Thompson, C. B. In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. Mol. Cell 6, 683–692 (2000).
  Article CAS PubMed Google Scholar
• Fox, C. J., Hammerman, P. S. & Thompson, C. B. Fuel feeds function: energy metabolism and the T cell response. Nat. Rev. Immunol. 5, 844–852 (2005).
  Article CAS PubMed Google Scholar
• Warburg, O., Wind, F. & Negelein, E. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519–530 (1927).
  Article CAS PubMed PubMed Central Google Scholar
• Warburg, O. On the origin of cancer cells. Science 123, 309–314 (1956).
  Article CAS PubMed Google Scholar
• Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–339 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Recondo, G., Facchinetti, F., Olaussen, K. A., Besse, B. & Friboulet, L. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI? Nat. Rev. Clin. Oncol. 15, 694–708 (2018).
  Article CAS PubMed Google Scholar
• Arteaga, C. L. et al. Treatment of HER2-positive breast cancer: current status and future perspectives. Nat. Rev. Clin. Oncol. 9, 16–32 (2011).
  Article PubMed CAS Google Scholar
• Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004).
  Article CAS PubMed Google Scholar
• Engelman, J. A., Luo, J. & Cantley, L. C. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat. Rev. Genet. 7, 606–619 (2006).
  Article CAS PubMed Google Scholar
• Lawrence, M. S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495–501 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Pavlova, N. N. & Thompson, C. B. The emerging hallmarks of cancer metabolism. Cell Metab. 23, 27–47 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Almuhaideb, A., Papathanasiou, N. & Bomanji, J. 18F-FDG PET/CT imaging in oncology. Ann. Saudi Med. 31, 3–13 (2011).
  Article PubMed PubMed Central Google Scholar
• Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
  Article CAS Google Scholar
• Faubert, B. et al. Lactate metabolism in human lung tumors. Cell 171, 358–371 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Hui, S. et al. Glucose feeds the TCA cycle via circulating lactate. Nature 551, 115–118 (2017). Faubert et al. (2017) and Hui et al. (2017) provide the first evidence that lactate in the circulation can act as the major carbon source to fuel the TCA cycle in vivo.
  Article PubMed PubMed Central CAS Google Scholar
• Palm, W. & Thompson, C. B. Nutrient acquisition strategies of mammalian cells. Nature 546, 234–242 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960–976 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648–657 (2002).
  Article CAS PubMed Google Scholar
• Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol. Cell 10, 151–162 (2002).
  Article CAS PubMed Google Scholar
• Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771–785 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. & Avruch, J. Rheb binds and regulates the mTOR kinase. Curr. Biol. 15, 702–713 (2005).
  Article CAS PubMed Google Scholar
• Edinger, A. L. & Thompson, C. B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276–2288 (2002). This study shows that AKT promotes cell survival and growth in part by maintaining nutrient transporter levels on the plasma membrane.
  Article CAS PubMed PubMed Central Google Scholar
• Hannan, K. M. et al. mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Mol. Cell. Biol. 23, 8862–8877 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Wolfson, R. L. & Sabatini, D. M. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 26, 301–309 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Saxton, R. A. et al. Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science 351, 53–58 (2016).
  Article CAS PubMed Google Scholar
• Wolfson, R. L. et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43–48 (2016).
  Article CAS PubMed Google Scholar
• Chantranupong, L. et al. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 165, 153–164 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Gu, X. et al. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 358, 813–818 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Lu, P. D., Harding, H. P. & Ron, D. Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response. J. Cell Biol. 167, 27–33 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Harding, H. P. et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619–633 (2003).
  Article CAS PubMed Google Scholar
• Sato, H. et al. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation. Biochem. Biophys. Res. Commun. 325, 109–116 (2004).
  Article CAS PubMed Google Scholar
• Lewerenz, J. & Maher, P. Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J. Biol. Chem. 284, 1106–1115 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Lopez, A. B. et al. A feedback transcriptional mechanism controls the level of the arginine/lysine transporter cat-1 during amino acid starvation. Biochem. J. 402, 163–173 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521–534 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, N. et al. Increased amino acid uptake supports autophagy-deficient cell survival upon glutamine deprivation. Cell Rep. 23, 3006–3020 (2018).
  Article CAS PubMed Google Scholar
• Shan, J. et al. The C/ebp-Atf response element (CARE) location reveals two distinct Atf4-dependent, elongation-mediated mechanisms for transcriptional induction of aminoacyl-tRNA synthetase genes in response to amino acid limitation. Nucleic Acids Res. 44, 9719–9732 (2016).
  CAS PubMed PubMed Central Google Scholar
• Ye, J. et al. GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2. Genes Dev. 29, 2331–2336 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Siu, F., Bain, P. J., LeBlanc-Chaffin, R., Chen, H. & Kilberg, M. S. ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene. J. Biol. Chem. 277, 24120–24127 (2002).
  Article CAS PubMed Google Scholar
• DeNicola, G. M. et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat. Genet. 47, 1475–1481 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Locasale, J. W. et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 43, 869–874 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Possemato, R. et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476, 346–350 (2011). Locasale et al. (2011) and Possemato et al. (2011) provide early evidence that the serine synthesis pathway is upregulated in cancer and that it is critical in mediating tumorigenesis.
  Article CAS PubMed PubMed Central Google Scholar
• Pacold, M. E. et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol. 12, 452–458 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Mullarky, E. et al. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proc. Natl Acad. Sci. USA 113, 1778–1783 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, M. & Vousden, K. H. Serine and one-carbon metabolism in cancer. Nat. Rev. Cancer 16, 650–662 (2016).
  Article CAS PubMed Google Scholar
• Maddocks, O. D. et al. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. Nature 493, 542–546 (2013).
  Article CAS PubMed Google Scholar
• Maddocks, O. D. K. et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation. Nature 544, 372–376 (2017).
  Article CAS PubMed Google Scholar
• Lane, A. N. & Fan, T. W. Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res. 43, 2466–2485 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Garcia-Bermudez, J. et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat. Cell Biol. 20, 775–781 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540–551 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Sullivan, L. B. et al. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162, 552–563 (2015). Birsoy et al. (2015) and Sullivan et al. (2015) demonstrate that a major function of the mitochondrial ETC is to support aspartate production.
  Article CAS PubMed PubMed Central Google Scholar
• Lauren, P. et al. Mitochondrial complex III is necessary for endothelial cell proliferation during angiogenesis. Nat. Metab. 1, 158–171 (2019).
  Article CAS Google Scholar
• Liu, X. et al. Regulation of mitochondrial biogenesis in erythropoiesis by mTORC1-mediated protein translation. Nat. Cell Biol. 19, 626–638 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Weinberg, S. E. et al. Mitochondrial complex III is essential for suppressive function of regulatory T cells. Nature 565, 495–499 (2019).
  Article CAS PubMed PubMed Central Google Scholar
• Alistar, A. et al. Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial. Lancet Oncol. 18, 770–778 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036–1046 (2018).
  Article CAS PubMed Google Scholar
• Sullivan, L. B. et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat. Cell Biol. 20, 782–788 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Swanson, J. A. Shaping cups into phagosomes and macropinosomes. Nat. Rev. Mol. Cell Biol. 9, 639–649 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Recouvreux, M. V. & Commisso, C. Macropinocytosis: a metabolic adaptation to nutrient stress in cancer. Front. Endocrinol. 8, 261 (2017).
  Article Google Scholar
• Finicle, B. T., Jayashankar, V. & Edinger, A. L. Nutrient scavenging in cancer. Nat. Rev. Cancer 18, 619–633 (2018).
  Article CAS PubMed Google Scholar
• Bloomfield, G. & Kay, R. R. Uses and abuses of macropinocytosis. J. Cell Sci. 129, 2697–2705 (2016).
  CAS PubMed Google Scholar
• Haigler, H. T., McKanna, J. A. & Cohen, S. Rapid stimulation of pinocytosis in human carcinoma cells A-431 by epidermal growth factor. J. Cell Biol. 83, 82–90 (1979).
  Article CAS PubMed Google Scholar
• Palm, W., Araki, J., King, B., DeMatteo, R. G. & Thompson, C. B. Critical role for PI3-kinase in regulating the use of proteins as an amino acid source. Proc. Natl Acad. Sci. USA 114, E8628–E8636 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Bar-Sagi, D. & Feramisco, J. R. Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science 233, 1061–1068 (1986).
  Article CAS PubMed Google Scholar
• Commisso, C. et al. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497, 633–637 (2013). This study shows that macropinocytosis promotes the use of extracellular protein as an amino acid source in RAS-transformed cells.
  Article CAS PubMed PubMed Central Google Scholar
• Palm, W. et al. The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1. Cell 162, 259–270 (2015). This work demonstrates that mTORC1 activity suppresses the use of extracellular protein as an amino acid source through macropinocytosis.
  Article CAS PubMed PubMed Central Google Scholar
• Garcia, D. & Shaw, R. J. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell 66, 789–800 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Kim, S. M. et al. PTEN deficiency and AMPK activation promote nutrient scavenging and anabolism in prostate cancer cells. Cancer Discov. 8, 866–883 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Nofal, M., Zhang, K., Han, S. & Rabinowitz, J. D. mTOR inhibition restores amino acid balance in cells dependent on catabolism of extracellular protein. Mol. Cell 67, 936–946 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Goldberg, I. J., Eckel, R. H. & Abumrad, N. A. Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways. J. Lipid Res. 50, S86–S90 (2009).
  Article PubMed PubMed Central CAS Google Scholar
• Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 7, 763–777 (2007).
  Article CAS PubMed Google Scholar
• Zaidi, N. et al. Lipogenesis and lipolysis: the pathways exploited by the cancer cells to acquire fatty acids. Prog. Lipid Res. 52, 585–589 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Medes, G., Thomas, A. & Weinhouse, S. Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res. 13, 27–29 (1953).
  CAS PubMed Google Scholar
• Gansler, T. S., Hardman, W. 3rd, Hunt, D. A., Schaffel, S. & Hennigar, R. A. Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival. Hum. Pathol. 28, 686–692 (1997).
  Article CAS PubMed Google Scholar
• Sebastiani, V. et al. Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol. Oncol. 92, 101–105 (2004).
  Article CAS PubMed Google Scholar
• Visca, P. et al. Fatty acid synthase (FAS) is a marker of increased risk of recurrence in lung carcinoma. Anticancer Res. 24, 4169–4173 (2004).
  CAS PubMed Google Scholar
• Mashima, T., Seimiya, H. & Tsuruo, T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br. J. Cancer 100, 1369–1372 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 541, 41–45 (2017).
  Article CAS PubMed Google Scholar
• Zhang, M. et al. Adipocyte-derived lipids mediate melanoma progression via FATP proteins. Cancer Discov. 8, 1006–1025 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Sounni, N. E. et al. Blocking lipid synthesis overcomes tumor regrowth and metastasis after antiangiogenic therapy withdrawal. Cell Metab. 20, 280–294 (2014).
  Article CAS PubMed Google Scholar
• Hochachka, P. W., Rupert, J. L., Goldenberg, L., Gleave, M. & Kozlowski, P. Going malignant: the hypoxia-cancer connection in the prostate. Bioessays 24, 749–757 (2002).
  Article CAS PubMed Google Scholar
• Ackerman, D. & Simon, M. C. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol. 24, 472–478 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, Z., Dales, N. A. & Winther, M. D. Opportunities and challenges in developing stearoyl-coenzyme A desaturase-1 inhibitors as novel therapeutics for human disease. J. Med. Chem. 57, 5039–5056 (2014).
  Article CAS PubMed Google Scholar
• Igal, R. A. Stearoyl CoA desaturase-1: new insights into a central regulator of cancer metabolism. Biochim. Biophys. Acta 1861, 1865–1880 (2016).
  Article CAS PubMed Google Scholar
• Kamphorst, J. J. et al. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc. Natl Acad. Sci. USA 110, 8882–8887 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ackerman, D. et al. Triglycerides promote lipid homeostasis during hypoxic stress by balancing fatty acid saturation. Cell Rep. 24, 2596–2605 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Vriens, K. et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature 566, 403–406 (2019).
  Article PubMed CAS PubMed Central Google Scholar
• Nosal, J. M., Switzer, R. L. & Becker, M. A. Overexpression, purification, and characterization of recombinant human 5-phosphoribosyl-1-pyrophosphate synthetase isozymes I and II. J. Biol. Chem. 268, 10168–10175 (1993).
  Article CAS PubMed Google Scholar
• Qian, X. et al. Conversion of PRPS hexamer to monomer by AMPK-mediated phosphorylation inhibits nucleotide synthesis in response to energy stress. Cancer Discov. 8, 94–107 (2018).
  Article CAS PubMed Google Scholar
• Graves, L. M. et al. Regulation of carbamoyl phosphate synthetase by MAP kinase. Nature 403, 328–332 (2000).
  Article CAS PubMed Google Scholar
• Sigoillot, F. D. et al. Nuclear localization and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD. J. Biol. Chem. 280, 25611–25620 (2005).
  Article CAS PubMed Google Scholar
• Ben-Sahra, I., Howell, J. J., Asara, J. M. & Manning, B. D. Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339, 1323–1328 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Robitaille, A. M. et al. Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 339, 1320–1323 (2013).
  Article CAS PubMed Google Scholar
• Wang, Y. & Hekimi, S. Understanding ubiquinone. Trends Cell Biol. 26, 367–378 (2016).
  Article CAS PubMed Google Scholar
• White, R. M. et al. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 471, 518–522 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Sykes, D. B. et al. Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia. Cell 167, 171–186 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Ducker, G. S. & Rabinowitz, J. D. One-carbon metabolism in health and disease. Cell Metab. 25, 27–42 (2017).
  Article CAS PubMed Google Scholar
• Ben-Sahra, I., Hoxhaj, G., Ricoult, S. J. H., Asara, J. M. & Manning, B. D. mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science 351, 728–733 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Shi, Y., Evans, J. E. & Rock, K. L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425, 516–521 (2003).
  Article CAS PubMed Google Scholar
• Boeynaems, J. M. & Communi, D. Modulation of inflammation by extracellular nucleotides. J. Invest. Dermatol. 126, 943–944 (2006).
  Article CAS PubMed Google Scholar
• Scheibner, K. A. et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177, 1272–1281 (2006).
  Article CAS PubMed Google Scholar
• Singer, A. J. & Clark, R. A. Cutaneous wound healing. N. Engl. J. Med. 341, 738–746 (1999).
  Article CAS PubMed Google Scholar
• Kalluri, R. The biology and function of fibroblasts in cancer. Nat. Rev. Cancer 16, 582–598 (2016).
  Article CAS PubMed Google Scholar
• Dvorak, H. F. Tumors: wounds that do not heal-redux. Cancer Immunol. Res. 3, 1–11 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Sullivan, W. J. et al. Extracellular matrix remodeling regulates glucose metabolism through TXNIP destabilization. Cell 175, 117–132 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Camps, J. L. et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl Acad. Sci. USA 87, 75–79 (1990).
  Article CAS PubMed PubMed Central Google Scholar
• Olumi, A. F. et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59, 5002–5011 (1999).
  CAS PubMed Google Scholar
• Curtis, M. et al. Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis. Cell Metab. 29, 141–155 (2018).
  Article PubMed CAS PubMed Central Google Scholar
• Keith, B. & Simon, M. C. Hypoxia-inducible factors, stem cells, and cancer. Cell 129, 465–472 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Trabold, O. et al. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Repair Regen. 11, 504–509 (2003).
  Article PubMed Google Scholar
• Kamphorst, J. J. et al. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res. 75, 544–553 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Pan, M. et al. Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nat. Cell Biol. 18, 1090–1101 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Muranen, T. et al. Starved epithelial cells uptake extracellular matrix for survival. Nat. Commun. 8, 13989 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Olivares, O. et al. Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat. Commun. 8, 16031 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Katheder, N. S. & Rusten, T. E. Microenvironment and tumors-a nurturing relationship. Autophagy 13, 1241–1243 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Sousa, C. M. et al. Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion. Nature 536, 479–483 (2016). This work shows that autophagic degradation and release of cellular constituents in pancreatic stellate cells can support the growth of pancreatic cancer cells.
  Article CAS PubMed PubMed Central Google Scholar
• Nieman, K. M. et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat. Med. 17, 1498–1503 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Rabinowitz, J. D. & White, E. Autophagy and metabolism. Science 330, 1344–1348 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kaur, J. & Debnath, J. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 16, 461–472 (2015).
  Article CAS PubMed Google Scholar
• Wyant, G. A. et al. NUFIP1 is a ribosome receptor for starvation-induced ribophagy. Science 360, 751–758 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Amaravadi, R., Kimmelman, A. C. & White, E. Recent insights into the function of autophagy in cancer. Genes Dev. 30, 1913–1930 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Karsli-Uzunbas, G. et al. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov. 4, 914–927 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Guo, J. Y. et al. Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev. 30, 1704–1717 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, S. et al. Pancreatic cancers require autophagy for tumor growth. Genes Dev. 25, 717–729 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, A. et al. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 4, 905–913 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Yang, A. et al. Autophagy sustains pancreatic cancer growth through both cell-autonomous and nonautonomous mechanisms. Cancer Discov. 8, 276–287 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Poillet-Perez, L. et al. Autophagy maintains tumour growth through circulating arginine. Nature 563, 569–573 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Allen, E. L. et al. Differential aspartate usage identifies a subset of cancer cells particularly dependent on OGDH. Cell Rep. 17, 876–890 (2016).
  Article CAS PubMed Google Scholar
• Ilic, N. et al. PIK3CA mutant tumors depend on oxoglutarate dehydrogenase. Proc. Natl Acad. Sci. USA 114, E3434–E3443 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Ye, J. et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 4, 1406–1417 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Muir, A. et al. Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition. eLife 6, e27713 (2017).
  Article PubMed PubMed Central Google Scholar
• Shin, C. S. et al. The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. Nat. Commun. 8, 15074 (2017).
  Article PubMed PubMed Central Google Scholar
• Kong, H. & Chandel, N. S. Regulation of redox balance in cancer and T cells. J. Biol. Chem. 293, 7499–7507 (2018).
  Article CAS PubMed Google Scholar
• Tonks, N. K. Redox redux: revisiting PTPs and the control of cell signaling. Cell 121, 667–670 (2005).
  Article CAS PubMed Google Scholar
• Tormos, K. V. et al. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab. 14, 537–544 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Weinberg, F. et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc. Natl Acad. Sci. USA 107, 8788–8793 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Schafer, Z. T. et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 461, 109–113 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• DeNicola, G. M. et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475, 106–109 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Harris, I. S. et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211–222 (2015).
  Article CAS PubMed Google Scholar
• Piskounova, E. et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527, 186–191 (2015). This work demonstrates that melanoma cells need to overcome the oxidative stress barrier in order to successfully metastasize.
  Article CAS PubMed PubMed Central Google Scholar
• Luengo, A., Gui, D. Y. & Vander Heiden, M. G. Targeting metabolism for cancer therapy. Cell Chem. Biol. 24, 1161–1180 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Parker, W. B. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem. Rev. 109, 2880–2893 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Cantley, L. C. The phosphoinositide 3-kinase pathway. Science 296, 1655–1657 (2002).
  Article CAS PubMed Google Scholar
• Manning, B. D. & Cantley, L. C. AKT/PKB signaling: navigating downstream. Cell 129, 1261–1274 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Manning, B. D. & Toker, A. AKT/PKB signaling: navigating the network. Cell 169, 381–405 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat. Rev. Cancer 2, 489–501 (2002).
  Article CAS PubMed Google Scholar